![Integrating Bioanalysis with Toxicokinetics and Pharmacokinetics at Quotient Sciences](/sites/default/files/2023-12/integrating-tk-pk-bioanalysis-quotient-sciences.png)
Case Study: Copper and Ceruloplasmin-Derived Copper Analysis
27 March 2024
Overview
A case study on how Quotient Sciences worked with a biotech company to validate assays for total copper by ICP-MS and ceruloplasmin-derived copper by LC-ICP-MS, also analyzing Wilson’s Disease patient samples using fully validated methods.
This project involved a biotech company with the mission of identifying, developing and providing access to innovative treatments to patients with rare diseases, with a focus on Wilson’s Disease.